Almirall Says to Continue with Lung Drug Trial Published: Oct 15, 2008 MADRID, Oct 15 (Reuters) - Spanish drug company Almirall said on Wednesday it plans to continue with trials for a drug to treat chronic lung disease with U.S. partner Forest Laboratories. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news